ArticleNature communications2026
An unexplored coupling process enhances dark Hg(II) reduction in mineral-Hg(II)-DOM ternary systems.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Photochemical and microbial-mediated reduction of mercury (Hg) are recognized as key processes and pathways for Hg geochemical cycling and atmospheric emissions. However, these processes cannot fully account for the total budget of global elemental Hg(0) production. Here we show that net Hg(0) production is significantly enhanced in a goethite-Hg(II)-DOM ternary system under dark conditions, representing a ubiquitous mineral-organic interface in surface ecosystems. This enhancement arises from the combined effects of preferential adsorption of monodentate [Hg-DOM]
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.